LATAM Gene Vector Market Size & Outlook, 2026-2034

LATAM Gene Vector Market Insights

According to Reed Intelligence analysis, the LATAM Gene Vector Market size stood at USD 171.92 Million in 2025 and is forecasted to reach USD 670.39 Million by 2034.
The market is projected to grow at a CAGR of 16.35% between 2026 and 2034.
By segment, Viral Vectors was the leading Vector Type in terms of market size in 2025.
Non-Viral Vectors is expected to be the most lucrative Vector Type segment, exhibiting the fastest growth throughout the forecast period.

Other Key Findings

LATAM represented 6.14% of the global Gene Vector Market size in 2025.
By 2034, United States is estimated to hold the largest position in the global market in terms of size.
Colombia is estimated to remain the fastest-growing market in LATAM, advancing to USD 56.4 Million by 2034.

Report Summary

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 171.92 Million
Market Size In 2034	USD 670.39 Million
Largest segment	Viral Vectors
Units	Revenue in USD Million
CAGR	16.35% (2026-2034)
Segmnetation Covered
LATAM	Brazil Mexico Argentina Colombia Chile
Vector Type	Viral Vectors Non-Viral Vectors
Application	Gene Therapy Vaccine Development Research Applications
End-Use	Biopharmaceutical Companies Research Institutes Contract Manufacturing Organizations
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

LATAM Gene Vector Market Country 2026-2034 (USD Million)

LATAM	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Brazil	XX.x	XX.x	XX.x	65.88	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Mexico	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Argentina	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Colombia	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Chile	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

LATAM Gene Vector Market Vector Type 2026-2034 (USD Million)

Vector Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Viral Vectors	XX.x	XX.x	XX.x	111.64	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Non-Viral Vectors	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

LATAM Gene Vector Market Application 2026-2034 (USD Million)

Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Gene Therapy	XX.x	XX.x	XX.x	84.53	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Vaccine Development	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Research Applications	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

LATAM Gene Vector Market End-Use 2026-2034 (USD Million)

End-Use	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Biopharmaceutical Companies	XX.x	XX.x	XX.x	87.25	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Research Institutes	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Contract Manufacturing Organizations	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.